£47.3M
The funding round was supported by Morningside Ventures and new private funds.
"There is tremendous need for technologies that can enable effective digital health and wellness, driven by the associated benefit provided to population health,"
Morningside
Venture CapitalMorningside Group was founded in 1986 by the Chan family of Hong Kong to make private equity and venture capital investments. The group is managed by entrepreneurial investment professionals.
Recent investments
£40.6M
The Boston investor backs the clinical stage biotechnology firm to advance its immune-resetting therapies.
"We have two clinical stage drug product candidates, '1805 and '1104, that have demonstrated impressive efficacy and safety data in phase 2a clinical studies on Rheumatoid Arthritis and Allergic Disease respectively and we are delighted to have Morningside as a partner to advance our programs,"
